• 1
    Ries LA, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2003. Bethesda, MD: National Cancer Institute; 2006.
  • 2
    Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin. 2007; 57: 242-255.
  • 3
    Loscalzo MJ, Clark KL. The psychosocial context of cancer-related infertility. Cancer Treat Res. 2007; 138: 180-190.
  • 4
    Guarneri V, Conte P. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist. 2009; 14: 645-656.
  • 5
    Bengala C, Bettelli S, Bertolini F, et al. Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer. Ann Oncol. 2009; 20: 469-474.
  • 6
    You DD, Lee HG, Heo JS, Choi SH, Choi DW. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. J Gastrointest Surg. 2009; 13: 1699-1706.
  • 7
    Schmiegelow ML, Sommer P, Carlsen E, Sonksen JO, Schmiegelow K, Muller JR. Penile vibratory stimulation and electroejaculation before anticancer therapy in 2 pubertal boys. J Pediatr Hematol Oncol. 1998; 20: 429-430.
  • 8
    Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009; 360: 902-911.
  • 9
    West ER, Zelinski MB, Kondapalli LA, et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer. 2009; 53: 289-295.
  • 10
    Lee D. Ovarian tissue cryopreservation, transplantation: banking reproductive potential for the future. Cancer Treat Res. 2007; 138: 110-129.
  • 11
    Agarwal SK, Chang RJ. Fertility management for women with cancer. Cancer Treat Res. 2007; 138: 15-27.
  • 12
    Anderson RA, Wallace WH, Baird DT. Ovarian cryopreservation for fertility preservation: indications and outcomes. Reproduction. 2008; 136: 681-689.
  • 13
    Porcu E, Bazzocchi A, Notarangelo L, Paradisi R, Landolfo C, Venturoli S. Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol Diabetes Obes. 2008; 15: 529-535.
  • 14
    Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004; 364: 1405-1410.
  • 15
    Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Orthotopic and heterotopic ovarian tissue transplantation. Hum Reprod Update. 2009; 15: 649-665.
  • 16
    Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005; 353: 318-321.
  • 17
    Demeestere I, Simon P, Buxant F, et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod. 2006; 21: 2010-204.
  • 18
    Andersen CY, Rosendahl M, Byskov AG, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008; 23: 2266-2272.
  • 19
    Donnez J, Jadoul P, Squifflet J, et al. Ovarian tissue cryopreservation and transplantation in cancer patients. Best Pract Res Clin Obstet Gynaecol. 2009; 24: 87-100.
  • 20
    Meirow D, Levron J, Eldar-Geva T, et al. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril. 2007; 87: 418 e7-418 e15.
  • 21
    Meirow D, Hardan I, Dor J, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008; 23: 1007-1013.
  • 22
    Xu M, Kreeger PK, Shea LD, Woodruff TK. Tissue-engineered follicles produce live, fertile offspring. Tissue Eng. 2006; 12: 2739-2746.
  • 23
    Telfer EE, McLaughlin M, Ding C, Thong KJ. A 2-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod. 2008; 23: 1151-118.
  • 24
    Xu M, Barrett SL, West-Farrell E, et al. In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum Reprod. 2009; 24: 2531-2540.
  • 25
    Jin SY, Lei L, Shikanov A, Shea LD, Woodruff TK. A novel 2-step strategy for in vitro culture of early-stage ovarian follicles in the mouse. Fertil Steril. 2009; 93: 2633-2639.
  • 26
    Mazzon I, Corrado G, Masciullo V, Morricone D, Ferrandina G, Scambia G. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril. 2009; 93: 1286-1289.
  • 27
    Wright JD, Shah M, Mathew L, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer. 2009; 115: 4118-4126.
  • 28
    Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery. Gynecol Oncol. 2009; 113: 75-82.
  • 29
    Fambrini M, Penna C, Pieralli A, et al. CO2 laser cylindrical excision or standard re-conization for persistent-recurrent high-grade cervical intraepithelial neoplasia (HG-CIN) in women of fertile age. Anticancer Res. 2008; 28: 3871-3875.
  • 30
    Nalesnik JG, Sabanegh ES,Jr, Eng TY, Buchholz TA. Fertility in men after treatment for stage 1 and 2A seminoma. Am J Clin Oncol. 2004; 27: 584-588.
  • 31
    Sieniawski M, Reineke T, Nogova L, et al. Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG). Blood. 2008; 111: 71-76.
  • 32
    Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone. Hum Reprod. 2009; 24: 982-990.
  • 33
    Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003; 88: 5307-5314.
  • 34
    Elizur SE, Tulandi T, Meterissian S, Huang JY, Levin D, Tan SL. Fertility preservation for young women with rectal cancer—a combined approach from 1 referral center. J Gastrointest Surg. 2009; 13: 1111-1115.
  • 35
    Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001; 7: 394-403.
  • 36
    Nurmio M, Keros V, Lahteenmaki P, Salmi T, Kallajoki M, Jahnukainen K. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility. J Clin Endocrinol Metab. 2009; 94: 2119-2122.
  • 37
    Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. 2007; 110: 2222-2229.
  • 38
    Pectasides D, Pectasides E, Papaxoinis G, et al. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy. J Androl. 2009; 30: 280-286.
  • 39
    Zekri JM, El-Helw LM, Purohit OP, Hatton MQ, Coleman RE. Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function. Clin Oncol (R Coll Radiol). 2008; 20: 513-516.
  • 40
    Spanos CP, Mamopoulos A, Tsapas A, Syrakos T, Kiskinis D. Female fertility and colorectal cancer. Int J Colorectal Dis. 2008; 23: 735-743.
  • 41
    Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004; 351: 2817-2826.
  • 42
    Tempest HG, Ko E, Chan P, Robaire B, Rademaker A, Martin RH. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin's lymphoma patients. Hum Reprod. 2008; 23: 251-258.
  • 43
    Backhus LE, Kondapalli LA, Chang RJ, Coutifaris C, Kazer R, Woodruff TK. Oncofertility consortium consensus statement: guidelines for ovarian tissue cryopreservation. Cancer Treat Res. 2007; 138: 235-239.
  • 44
    Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med. 2000; 343: 1086-1094.
  • 45
    West ER, Zelinski MB, Kondapalli LA, et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer. 2009; 53: 289-295.
  • 46
    Falcone T, Attaran M, Bedaiwy MA, Goldberg JM. Ovarian function preservation in the cancer patient. Fertil Steril. 2004; 81: 243-257.
  • 47
    Gradishar WJ, Hellmund R. A rationale for the reinitiation of adjuvant tamoxifen therapy in women receiving fewer than 5 years of therapy. Clin Breast Cancer. 2002; 2: 282-286.
  • 48
    Blakely LJ, Buzdar AU, Lozada JA, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004; 100: 465-469.
  • 49
    Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007; 334: 194.
  • 50
    Gupta PB, Kuperwasser C. Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol. 2006; 102: 71-78.
  • 51
    Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005; 83: 1622-1628.
  • 52
    Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24: 2917-2931.
  • 53
    Quinn GP, Vadaparampil ST, King L, Miree CA, et al. Impact of physicians' personal discomfort and patient prognosis on discussion of fertility preservation with young cancer patients. Patient Educ Couns. 2009; 77: 338-343.